Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer's disease pathogenesis.
Hoau-Yan WangCaryn Trocmé-ThibiergeAndres StuckySanket M ShahJessica KvasicAmber KhanPhilippe MorainIsabelle GuignotEva BouguenKarine DeschetMaria PueyoElisabeth MocaerPierre-Jean OussetBruno VellasVera KiyasovaPublished in: Alzheimer's research & therapy (2017)
Our data suggest that increased lymphocyte Aβ42-α7nAChR-like complexes may indicate the presence of AD pathology especially in APOE ε4 carriers. We show that apoE, especially apoE4, promotes Aβ42-α7nAChR interaction and Aβ42-induced α7nAChR-dependent tau phosphorylation via its apoE141-148 domain. These apoE-mediated effects may contribute to the APOE ε4-driven neurodysfunction and AD pathologies.